Table 1

Historical data and falls among 101 patients with Parkinson's disease

CharacteristicFallers (n=69)Non-fallers (n=32)Testp Value
Data are median with range or absolute number with percentages. **p<0.01. 1, independent samples t test; 2, χ2 test; 3, Mann-Whitney U test.
Age (years)75 (54–92)75 (60–92)10.526
Male sex37 (53.6%)13 (40.6%)20.224
Duration of symptoms (years)6 (1–37)4.5 (1–11)30.006**
In long term care (years)6 (8.7%)1 (3.1%)20.427
Number of falls in previous year3 (0–500)0 (0–5)3<0.001**
History of any fall50 (72.5%)12 (37.5%)20.003**
History of recurrent falls43 (62.3%)5 (15.6%)2<0.001**
Levodopa dose (mg)400 (0–1250)375 (0–800)10.102
Dopamine agonist use10 (14.5%)8 (25%)20.199
Benzodiazepine use6 (8.7%)3 (9.4%)20.911
Polypharmacy7 (10.1%)5 (15.6%)20.428